Stock Scorecard
Stock Summary for NeuroOne Medical Technologies Corp (NMTC) - $0.74 as of 9/4/2025 2:09:29 PM EST
Total Score
11 out of 30
Safety Score
9 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for NMTC
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for NMTC
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for NMTC
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for NMTC
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for NMTC (9 out of 100)
| Stock Price Rating (Max of 10) | 1 |
| Historical Stock Price Rating (Max of 10) | 2 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 4 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for NMTC
Financial Details for NMTC
Company Overview |
|
|---|---|
| Ticker | NMTC |
| Company Name | NeuroOne Medical Technologies Corp |
| Country | USA |
| Description | NeuroOne Medical Technologies Corporation is a medical technology company. The company is headquartered in Eden Prairie, Minnesota. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 0.74 |
| Price 4 Years Ago | 1.94 |
| Last Day Price Updated | 9/4/2025 2:09:29 PM EST |
| Last Day Volume | 161,562 |
| Average Daily Volume | 266,412 |
| 52-Week High | 1.39 |
| 52-Week Low | 0.40 |
| Last Price to 52 Week Low | 85.00% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 35.62 |
| Sector PE | 40.17 |
| 5-Year Average PE | -5.29 |
| Free Cash Flow Ratio | 4.63 |
| Industry Free Cash Flow Ratio | 28.10 |
| Sector Free Cash Flow Ratio | 28.68 |
| Current Ratio Most Recent Quarter | 7.13 |
| Total Cash Per Share | 0.16 |
| Book Value Per Share Most Recent Quarter | 0.16 |
| Price to Book Ratio | 4.67 |
| Industry Price to Book Ratio | 4.28 |
| Sector Price to Book Ratio | 45.62 |
| Price to Sales Ratio Twelve Trailing Months | 5.43 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.94 |
| Sector Price to Sales Ratio Twelve Trailing Months | 11.64 |
| Analyst Buy Ratings | N/A |
| Analyst Strong Buy Ratings | N/A |
Share Statistics |
|
| Total Shares Outstanding | 49,999,500 |
| Market Capitalization | 36,999,630 |
| Institutional Ownership | 33.63% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -3.87% |
| Reported EPS 12 Trailing Months | -0.16 |
| Reported EPS Past Year | -0.04 |
| Reported EPS Prior Year | -0.46 |
| Net Income Twelve Trailing Months | -5,336,748 |
| Net Income Past Year | -12,318,110 |
| Net Income Prior Year | -11,859,491 |
| Quarterly Revenue Growth YOY | 105.40% |
| 5-Year Revenue Growth | 613.83% |
| Operating Margin Twelve Trailing Months | -111.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 8,039,683 |
| Total Cash Past Year | 1,460,042 |
| Total Cash Prior Year | 5,322,493 |
| Net Cash Position Most Recent Quarter | 8,039,683 |
| Net Cash Position Past Year | 1,460,042 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 1,007,206 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 822,013 |
| Total Stockholder Equity Prior Year | 6,249,404 |
| Total Stockholder Equity Most Recent Quarter | 8,177,453 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -4,086,523 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.08 |
| Free Cash Flow Past Year | -11,132,037 |
| Free Cash Flow Prior Year | -13,270,991 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.01 |
| MACD Signal | 0.01 |
| 20-Day Bollinger Lower Band | 0.51 |
| 20-Day Bollinger Middle Band | 0.69 |
| 20-Day Bollinger Upper Band | 0.88 |
| Beta | 0.68 |
| RSI | 44.46 |
| 50-Day SMA | 0.83 |
| 150-Day SMA | 1.11 |
| 200-Day SMA | 1.25 |
System |
|
| Modified | 9/4/2025 5:48:58 AM EST |